ANG Lifesciences India Reports Mixed Financial Results Amid Declining Sales Trends in March 2025
ANG Lifesciences India has announced its financial results for the quarter ending March 2025, showcasing a notable increase in earnings per share, while facing significant challenges with a sharp decline in net sales and profitability metrics. The company continues to navigate a difficult market environment.
ANG Lifesciences India has recently reported its financial results for the quarter ending March 2025, revealing notable trends within its performance metrics. The company has experienced a revision in its evaluation, with its score adjusting to -9 from -14 over the past three months.In terms of earnings, ANG Lifesciences achieved its highest earnings per share (EPS) in the last five quarters, recorded at Rs -1.58, indicating a shift towards higher earnings for shareholders. However, the company faces significant challenges as reflected in its net sales, which totaled Rs 16.82 crore, marking a substantial decline of 55.55% year on year. This figure represents the lowest sales recorded in the last five quarters, suggesting a concerning near-term sales trend.
Additionally, the profit before tax (PBT) was reported at Rs -4.54 crore, a decrease of 79.45% year on year, further emphasizing the negative trajectory in profitability. The profit after tax (PAT) also reflected a decline, recorded at Rs -2.06 crore, down 7.9% year on year. These results highlight the ongoing difficulties faced by ANG Lifesciences in the current market environment.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
